Cite
HARVARD Citation
Kuehl, P. et al. (2018). Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model. Drug delivery. pp. 1127-1136. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kuehl, P. et al. (2018). Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model. Drug delivery. pp. 1127-1136. [Online].